Bevacizumab Therapy for Brain Arteriovenous Malformation
Clinical trial NCT02314377 · COMPLETED
Trial details
- NCT number
- NCT02314377
- Sponsor
- University of California, San Francisco
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2018-12-01
- Enrollment
- 2
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.